Brown Advisory Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25,133
| Closed | -$1.31M | – | 105 |
|
|
2022
Q2 | $1.31M | Sell |
25,133
-1,550
| -6% | -$79K | 1.24% | 18 |
|
|
2022
Q1 | $1.38M | Sell |
26,683
-2,492
| -9% | -$129K | 0.81% | 31 |
|
|
2021
Q4 | $1.73M | Sell |
29,175
-24,417
| -46% | -$1.21M | 0.74% | 29 |
|
|
2021
Q3 | $2.31M | Sell |
53,592
-5,411
| -9% | -$240K | 0.68% | 36 |
|
|
2021
Q2 | $2.31M | Buy |
59,003
+2,094
| +4% | +$81.4K | 0.36% | 54 |
|
|
2021
Q1 | $2.06M | Sell |
56,909
-5,676
| -9% | -$202K | 0.35% | 56 |
|
|
2020
Q4 | $2.3M | Sell |
62,585
-2,989
| -5% | -$110K | 0.39% | 51 |
|
|
2020
Q3 | $2.28M | Buy |
65,574
+708
| +1% | +$24.8K | 0.47% | 49 |
|
|
2020
Q2 | $2.17M | Sell |
64,866
-3,178
| -5% | -$108K | 0.46% | 51 |
|
|
2020
Q1 | $2.23M | Sell |
68,044
-1,051
| -2% | -$35.8K | 0.57% | 45 |
|
|
2019
Q4 | $2.57M | Buy |
69,095
+13,221
| +24% | +$471K | 0.62% | 40 |
|
|
2019
Q3 | $1.9M | Sell |
55,874
-4,743
| -8% | -$172K | 0.54% | 45 |
|
|
2019
Q2 | $2.49M | Sell |
60,617
-9,688
| -14% | -$385K | 0.66% | 37 |
|
|
2019
Q1 | $2.83M | Sell |
70,305
-23,021
| -25% | -$922K | 0.67% | 43 |
|
|
2018
Q4 | $3.83M | Buy |
93,326
+1,714
| +2% | +$71.2K | 0.73% | 36 |
|
|
2018
Q3 | $3.83M | Sell |
91,612
-2,532
| -3% | -$97.5K | 0.61% | 42 |
|
|
2018
Q2 | $3.24M | Buy |
94,144
+952
| +1% | +$32.5K | 0.56% | 43 |
|
|
2018
Q1 | $3.14M | Buy |
93,192
+17,214
| +23% | +$592K | 0.58% | 42 |
|
|
2017
Q4 | $2.6M | Buy |
75,978
+1,640
| +2% | +$55.9K | 0.5% | 49 |
|
|
2017
Q3 | $2.52M | Buy |
74,338
+5,313
| +8% | +$171K | 0.54% | 50 |
|
|
2017
Q2 | $2.2M | Buy |
69,025
+5,769
| +9% | +$182K | 0.51% | 50 |
|
|
2017
Q1 | $2.05M | Buy |
63,256
+4,032
| +7% | +$127K | 0.51% | 50 |
|
|
2016
Q4 | $1.82M | Buy |
59,224
+6,861
| +13% | +$209K | 0.5% | 56 |
|
|
2016
Q3 | $1.69M | Buy |
52,363
+1,406
| +3% | +$47K | 0.49% | 57 |
|
|
2016
Q2 | $1.71M | Buy |
50,957
+342
| +0.7% | +$10.9K | 0.53% | 52 |
|
|
2016
Q1 | $1.42M | Buy |
50,615
+2,422
| +5% | +$69.2K | 0.47% | 56 |
|
|
2015
Q4 | $1.48M | Buy |
48,193
+498
| +1% | +$15.7K | 0.5% | 51 |
|
|
2015
Q3 | $1.42M | Sell |
47,695
-741
| -2% | -$23.8K | 0.51% | 49 |
|
|
2015
Q2 | $1.54M | Sell |
48,436
-1
| -0% | -$33 | 0.51% | 48 |
|
|
2015
Q1 | $1.6M | Sell |
48,437
-391
| -0.8% | -$12.4K | 0.55% | 46 |
|
|
2014
Q4 | $1.44M | Sell |
48,828
-1,284
| -3% | -$36.8K | 0.52% | 47 |
|
|
2014
Q3 | $1.41M | Buy |
50,112
+1,766
| +4% | +$49.6K | 0.52% | 45 |
|
|
2014
Q2 | $1.36M | Sell |
48,346
-77
| -0.2% | -$2.19K | 0.49% | 48 |
|
|
2014
Q1 | $1.48M | Buy |
48,423
+2,910
| +6% | +$86.8K | 0.58% | 45 |
|
|
2013
Q4 | $1.32M | Buy |
45,513
+1,276
| +3% | +$37.1K | 0.53% | 47 |
|
|
2013
Q3 | $1.2M | Buy |
44,237
+942
| +2% | +$25.6K | 0.53% | 47 |
|
|
2013
Q2 | $1.15M | Buy |
+43,295
| New | +$1.2M | 0.56% | 48 |
|
Other funds holding PFE
Brown Advisory Securities's PFE Position: Q3 2022 in Review
Brown Advisory Securities sold out of Pfizer (PFE) in Q3 2022, closing a stake of 25,133 shares — an estimated $1.31M sold.
Brown Advisory Securities first reported a position in PFE in Q2 2013 and held it in 37 quarters. The position peaked at $3.83M in Q4 2018. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Brown Advisory Securities reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
- Brown Advisory Securities sold 25,133 Pfizer shares in Q3 2022, an estimated $1.31M.
- Brown Advisory Securities first reported a position in Pfizer in Q2 2013 and held it in 37 quarters.
- Brown Advisory Securities's Pfizer position peaked at $3.83M in Q4 2018.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Brown Advisory Securities's 13F filing for Q3 2022, filed 14 Nov 2022.